NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-234-2012-0-EP-13 PAK Inhibitors For the Treatment of Fragile X Syndrome EP National Stage 12845870.0 Abandoned
NCATS E-234-2012-0-UA-25 PAK Inhibitors For the Treatment of Fragile X Syndrome UA National Stage 201406114 Pending
NCATS E-234-2012-0-TH-24 PAK Inhibitors For the Treatment of Fragile X Syndrome TH National Stage 1401002411 Pending
NCATS E-234-2012-0-MY-20 PAK Inhibitors For the Treatment of Fragile X Syndrome MY National Stage PI 2014001294 Pending
NCATS E-234-2012-0-CO-06 PAK Inhibitors For the Treatment of Fragile X Syndrome CO National Stage 14119.699 Abandoned
NCATS E-234-2012-0-CA-07 PAK Inhibitors For the Treatment of Fragile X Syndrome CA National Stage 2854462 Abandoned
NEI E-248-2012-0-US-01 METHOD OF REDUCING ADVERSE EFFECTS IN A CANCER PATIENT DURING TREATMENT WITH A MEK INHIBITOR US 61/721,810 Abandoned
NCATS E-234-2012-0-AU-30 PAK Inhibitors For the Treatment of Fragile X Syndrome AU National Stage 2012327187 Abandoned
NCATS E-234-2012-0-SG-23 PAK Inhibitors For the Treatment of Fragile X Syndrome SG National Stage 11201401996T Pending
NIDCR E-160-2000-1-US-07 T2R, A NOVEL FAMILY OF TASTE RECEPTORS US CON 13/666,740 8624012 Expired PDF
NIAID E-299-2011-0-PCT-02 Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines PCT PCT PCT/US2012/062998 Expired
NCI E-086-2006-0-US-21 Anti-Mart-1 T Cells Receptors And Related Materials And Methods Of Use US DIV 13/667,036 Abandoned
NIAID E-299-2011-0-BR-04 Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines BR National Stage 1120120277405 Pending
NCI E-050-2010-0-US-03 METHOD OF SENSITIZING CANCER CELLS TO THE CYTOTOXIC EFFECTS OF DEATH RECEPTOR LIGANDS IN CANCER TREATMENT US National Stage 13/516,514 9238069 Issued PDF
NCI E-224-2011-0-PCT-02 METHOD OF TREATING HCV INFECTION WITH A SMALL MOLECULE CHK2 INHIBITOR PCT PCT PCT/US12/62212 Expired
NIAID E-160-2010-1-US-02 Method of Treating HIV Infection: Inhibition of DNA Dependent Protein Kinase US National Stage 13/643,819 Abandoned
NCATS E-120-2010-0-US-07 Activators Of Human Pyruvate Kinase US National Stage 13/643,594 Abandoned
NCI E-224-2011-0-CN-03 METHOD OF TREATING HCV INFECTION WITH A SMALL MOLECULE CHK2 INHIBITOR CN National Stage 2012800648297 Abandoned
NCI E-224-2011-0-EP-04 METHOD OF TREATING HCV INFECTION WITH A SMALL MOLECULE CHK2 INHIBITOR EP National Stage 12783789.6 Abandoned
NCATS E-091-2013-0-US-01 Method For Identifying And Identification Of Small Molecule Inhibitors Of SIX/EYA Interaction For The Treatment Of Cancers US 61/718,659 Abandoned
NCATS E-091-2013-1-US-01 Method For Identifying And Identification Of Small Molecule Inhibitors Of SIX/EYA Interaction For The Treatment Of Cancers US 61/718,682 Abandoned
NCI E-291-2012-0-US-01 M971 Chimeric Antigen Receptors US 61/717,960 Abandoned
NCI E-054-2013-0-US-01 THERAPEUTIC USES OF IL-15 AND IL-15RALPHA HETERODIMER COMPLEXES US 61/718,169 Abandoned
NCI E-272-2012-0-US-01 Compositions And Methods For Enhancing Cancer Immunotherapy US 61/716,653 Abandoned
NCI E-265-2011-0-IN-08 Anti-CD22 Chimeric Antigen Receptors IN National Stage 2906/CHENP/2014 Abandoned
NCI E-265-2011-0-CA-05 Anti-CD22 Chimeric Antigen Receptors CA National Stage 2851795 Abandoned
NCI E-265-2011-0-EP-07 Anti-CD22 Chimeric Antigen Receptors EP National Stage 12781544.7 Abandoned
NCI E-265-2011-0-PCT-02 Anti-CD22 Chimeric Antigen Receptors PCT PCT PCT/US2012/061025 Expired
NIEHS E-180-2011-5-US-01 METHOD OF IDENTIFYING AND TREATING A PATIENT HAVING A GENETIC PREDISPOSITION TO PARKINSON DISEASE US CIP 13/574,000 Abandoned
NCI E-265-2011-0-AU-03 Anti-CD22 Chimeric Antigen Receptors AU National Stage 2012325915 Abandoned
NCI E-220-2011-0-CA-04 HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER CA National Stage 2852682 Issued
NCI E-220-2011-0-AU-03 HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER AU National Stage 2012326105 Issued
NCI E-220-2011-0-EP-05 HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER EP National Stage 12841601.3 Issued
NCI E-220-2011-0-PCT-02 HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER PCT PCT PCT/US2012/060785 Expired
NCATS E-010-2013-0-US-01 Point of Care Detection of Hyperammonemia and Aminoacidopathies US 61/714,870 Expired
NCI E-212-2011-0-PCT-02 Monospecific And Bispecific Human Monoclonal Antibodies Targeting Insulin-Like Growth Factor II (IGF-II) PCT PCT PCT/US2012/060443 Expired
NIA E-092-2011-0-CN-11 The Use Of (2r, 6r)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoisomeric Dehydro And Hydroxylated Metabolites Of (R,S)- Ketamine In The Treatment Of Depression And Neuropathic Pain CN DIV 201910105053.2 Issued
NIA E-092-2011-0-CA-04 The Use Of (2S,6S)-Hydroxynorketamine, (S)-Dehydronorketamine, And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain CA National Stage 2851619 Issued
NIA E-092-2011-0-DE-14 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain DE EP 12783752.4 Issued
NIA E-092-2011-0-FR-15 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain FR EP 12783752.4 Issued
NIA E-092-2011-0-EP-06 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain EP National Stage 12783752.4 Issued
NIA E-092-2011-0-IT-18 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain IT EP 12783752.4 Issued
NIA E-092-2011-0-GB-16 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain GB EP 12783752.4 Issued
NIA E-092-2011-0-ES-17 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain ES EP 12783752.4 Issued
NIA E-092-2011-0-AU-03 The Use Of (2R,6R)-hydroxynorketamine, (S)-dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain AU National Stage 2012323845 Issued
NIA E-092-2011-0-PCT-02 The Use Of (2S,6S)-hydroxynorketamine And Other Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression PCT PCT PCT/US12/60256 Expired
NCATS E-109-2010-0-US-06 Arylthiazolyl Piperidines And Related Compounds As Modulators Of Survival Motor Neuron (SMN) Protein Production US National Stage 13/641,383 Abandoned
NIAAA E-211-2006-0-US-07 Therapeutic Applications Of Fatty Acid Amide Hydrolase Inhibitors US CON 13/652,324 Abandoned
NIA E-092-2011-0-CN-05 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoisomeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain CN National Stage 201280062294X Pending
NIDCR E-114-2003-0-US-05 Methods and Compositions for the Inhibition of HIV-1 Replication US DIV 13/650,526 Abandoned